We pledge to provide
unlimited amounts of pure myoblasts and collaboration for
biomedical scientists and physicians to develop treatments
for debilitating and fatal diseases.
We believe that through
myoblasts and human genome transfer, many debilitating and
fatal diseases can be treated.
Company History
Cell Transplants Singapore Pte. Ltd. (CTS)
was established on May 20, 2000, upon the vision of Prof.
Peter K Law, inventor of Myoblast Genome Therapy. Prof. Law
holds world patents in this cutting edge platform biotechnology.
CTS inherits Prof. Law's trade secrets in cell proliferation,
transport and implantation. CTS holds the exclusive license
of Prof. Law's Singapore's patents.
With a team of dedicated scientists and personnel
skilled in cell manufacturing and quality assurance / quality
control, the CTS facility is able to produce pure myoblasts
by the billions for research and treatment.
Located at the Alpha in Science Park II,
CTS occupies a space of 5,000 sq ft and is fully equipped
to provide a cGMP, and ISO9001 certified facility for the
following:
Class 10,000 cleanroom for Cell Culture
Production
Class 10,000 cleanroom
for Medium and Buffer Preparation
QC Laboratory
Cryopreservation
Facility
Cold Room for
Medium and Buffer Storage
Receiving and
Quarantine Area
Material Storage
and Inventory
Autoclaving and
Utility Areas
Letter From The Chairman
Dear All,
It is my lifelong goal to save human lives
and relieve human sufferings related to
debilitating and fatal diseases with no
known cure. Some of us might have loved
ones stricken with hereditary diseases with
heart, bone or muscle degeneration. Others
may be incapacitated by Type II diabetes,
depression or intractable pain.
Cell Transplants Singapore
Pte. Ltd. (CTS) is dedicated to finding
cures for these diseases. Its platform technology
of myoblast genome therapy is at the cutting
edge of Cell Transplantation, Gene Therapy
and Tissue Engineering. The technology comes
after 33 years of painstaking efforts of
many experts and professionals.
It is my dream that you
will join us in this race for life. Together
we will establish a better tomorrow for
the sick and their loved ones. We will improve
the patients' quality of life and prolong
their lifespans through vigorous biomedical
research and stringent clinical trials.
We appreciate any support
and guidance that you may offer. It is through
your continual support that we will one
day achieve our common goal.
Prof. Peter K. Law
Founder & Chairman
Dr. Law's Presentation
On News Release In Singapore September 2003
